Part of Oral Answers to Questions — Prime Minister – in the House of Commons at 11:30 am on 7 May 2014.
The Pfizer bid for AstraZeneca is driven by tax advantages. Has the Prime Minister spoken to the US Government about whether they propose any changes to their tax law, and has Pfizer asked for any changes to our tax system, particularly to the patent box?